| Health effects and known pathology associated with the use of E-cigarettes M Esteban-Lopez, MD Perry, LD Garbinski, M Manevski, M Andre, ... Toxicology reports 9, 1357-1368, 2022 | 55 | 2022 |
| From alpha to omicron: how different variants of concern of the SARS-Coronavirus-2 impacted the world M Andre, LS Lau, MD Pokharel, J Ramelow, F Owens, J Souchak, ... Biology 12 (9), 1267, 2023 | 50 | 2023 |
| Blood-brain barrier dysfunction underlying Alzheimer's disease is induced by an SSAO/VAP-1-dependent cerebrovascular activation with enhanced Aβ deposition M Sole, M Esteban-Lopez, B Taltavull, C Fabregas, R Fadó, N Casals, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1865 (9 …, 2019 | 28 | 2019 |
| Diverse functions of insulin-like 3 peptide M Esteban-Lopez, AI Agoulnik Journal of Endocrinology 247 (1), R1-R12, 2020 | 27 | 2020 |
| The Impact of CRISPR-Cas9 on age-related disorders: from pathology to therapy A Caobi, RK Dutta, LD Garbinski, M Esteban-Lopez, Y Ceyhan, M Andre, ... Aging and disease 11 (4), 895, 2020 | 18 | 2020 |
| Signaling pathways and therapeutic perspectives related to environmental factors associated with multiple sclerosis S Tiwari, J Lapierre, CR Ojha, K Martins, T Parira, RK Dutta, A Caobi, ... Journal of Neuroscience Research 96 (12), 1831-1846, 2018 | 18 | 2018 |
| Discovery of small molecule agonists of the Relaxin Family Peptide Receptor 2 M Esteban-Lopez, KJ Wilson, C Myhr, EM Kaftanovskaya, MJ Henderson, ... Communications Biology 5 (1), 1183, 2022 | 6 | 2022 |
| Targeting the relaxin/insulin-like family peptide receptor 1 and 2 with small molecule compounds HH Ng, M Esteban-Lopez, AI Agoulnik Molecular and cellular endocrinology 487, 40-44, 2019 | 6 | 2019 |
| Health effects and known pathology associated with the use of E-cigarettes. Toxicol Rep. 2022; 9: 1357-68 M Esteban-Lopez, MD Perry, LD Garbinski, M Manevski, M Andre, ... | 5 | |
| Structural elucidation of RXFP2 allosteric agonist (compound-6641) binding: A computational and experimental approach A Kapoor, M Esteban-Lopez, KJ Wilson, AI Agoulnik, MJ Henderson, ... Biophysical Journal 123 (3), 98a, 2024 | | 2024 |
| RXFP2 Small Molecule Agonists: Potential Therapeutics for Osteoporosis M Esteban‐Lopez, K Wilson, C Myhr, E Kaftanovskaya, M Henderson, ... The FASEB Journal 36, 2022 | | 2022 |
| Discovery of First-in-Class Small Molecule Agonists of the RXFP2 Receptor as Therapeutic Candidates for Osteoporosis M Esteban Lopez | | 2022 |
